What's new

Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Preparing for a potential second COVID-19 wave. Joint statement by Medicines for Europe and EFPIA with Kearney

22 June 2020

Policy

Open

LESSONS LEARNED FROM COVID-19 – POLICY PAPER

22 June 2020

Policy

Open

Questions and answers on regulatory expectations for medicinal products for human use during the COVID-19 pandemic

10 April 2020

External Resource

Open

Why is Now the Right Time to Modernise the Eu Variations System?

30 January 2020

Report

Open

AMR Industry Alliance 2020 Progress Report

16 January 2020

Report

Open

Biosimilars in the EU – Information guide for healthcare professionals – now available in 23 languages

29 October 2019

External Resource

Unofficial Ukrainian translation (PDF/600 KB) (PDF/600 KB) English (PDF/1.85 MB) […]

Read more

Overarching recommendations for improved access to generic and biosimilar medicines in the hospital setting

7 October 2019

Report

Open

Improving healthcare delivery in hospitals by optimized utilization of medicines

7 October 2019

Report

Open

Open letter to the Members of the European Parliament on the importance to sustain EU progress in fighting against antimicrobial resistance (AMR)

11 September 2019

Policy

Open

Medicines for Europe Commentary on the Draft EMA regulatory science strategy 2025

28 June 2019

Policy

Open

Subscribe to our newsletter